Literature DB >> 17381646

The impact of hypertension and hypertension-related left ventricle hypertrophy on right ventricle function.

M Murat Tumuklu1, Unal Erkorkmaz, Arslan Ocal.   

Abstract

AIM: The aim of our study is to determine the effect of hypertension and hypertension-related left ventricle hypertrophy on right ventricle (RV) morphology and function by using RV standard Doppler echocardiographic indices, myocardial Doppler imaging, and strain/strain rate imaging indices.
METHODS: We studied 35 patients with arterial hypertension and 30 age- and sex-adjusted control subjects who had no other pathological conditions. Standard transthoracic Doppler echocardiographical measurements, pulsed-wave tissue Doppler from tricuspid anulus (Peak systolic-st, peak early diastolic-et, peak late diastolic velocity-at), reconstructed spectral pulsed-wave tissue Doppler velocities (peak systolic-S, peak early-E, peak late diastolic velocity-A), and strain/strain rate imaging of RV free wall mid region (peak systolic strain-in, peak systolic strain rate-SR) were obtained.
RESULTS: Age, body surface area, blood pressure, and heart rate were comparable between two groups. Hypertensive subjects had significantly increased LV end-diastolic septal and posterior wall thickness, left atrial diameter, LV mass, LV mass index, and relative wall thickness during diastole. At the level of right ventricular lateral tricuspid annulus without systolic changes, the majority of diastolic measurements were altered in hypertensives (early diastolic velocity et; 13 +/- 2 vs. 18 +/- 4 m/sec, P < 0.0001, late diastolic velocity at; 20 +/- 4 vs. 14 +/- 3 m/sec, P < 0.0001, early to late diastolic velocity ratio; 0.69 +/- 0.14 vs. 1.32 +/- 0.38, P < 0.0001). The velocity data from two-dimensional color myocardial imaging at the level of RV free wall mid region again showed altered diastolic measurements in hypertensives (E; 8.01 +/- 2.6 vs. 10.4 +/- 3.14 m/sec, P < 0.001, A; 11.5 +/- 2.6 vs. 9.12 +/- 3.7 m/sec, P < 0.0001, E/A ratio; 0.75 +/- 0.41 vs. 1.87 +/- 0.48, P < 0.00). The peak systolic strain of RV free wall mid region was significantly lower in hypertensive individuals than controls (25.666 +/- 5.64 vs. 30.03 +/- 6.78%, P < 0.05). No significant differences were found in other parameters of RV function between hypertensive and control subjects.
CONCLUSIONS: The present study demonstrates that besides the manifest morphologic LV adaptations, significant RV functional alterations can be determined by TDI and strain/strain rate imaging in patients arterial hypertension. Both tissue velocities by TDI and strain imaging may be new tools to define and quantitate subtle change in systolic and diastolic function of right ventricular function in arterial hypertension that cannot be determined in standard echocardiographic parameters.

Entities:  

Mesh:

Year:  2007        PMID: 17381646     DOI: 10.1111/j.1540-8175.2007.00419.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  16 in total

1.  Tissue Doppler-derived diastolic myocardial velocities are abnormal in pediatric cardiac transplant recipients in the absence of endomyocardial rejection.

Authors:  Sebastian Strigl; Rose Hardy; Julie S Glickstein; Daphne T Hsu; Linda J Addonizio; Jacqueline M Lamour; Ashwin Prakash
Journal:  Pediatr Cardiol       Date:  2008-01-05       Impact factor: 1.655

Review 2.  Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.

Authors:  Chike C Nwabuo; Ramachandran S Vasan
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

3.  Estrogen receptor-beta prevents cardiac fibrosis.

Authors:  Ali Pedram; Mahnaz Razandi; Fiona O'Mahony; Dennis Lubahn; Ellis R Levin
Journal:  Mol Endocrinol       Date:  2010-09-01

4.  Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients.

Authors:  Angela Sciacqua; Maria Perticone; Sofia Miceli; Angelina Pinto; Velia Cassano; Elena Succurro; Francesco Andreozzi; Marta Letizia Hribal; Giorgio Sesti; Francesco Perticone
Journal:  Endocrine       Date:  2019-02-21       Impact factor: 3.633

5.  Relation of cardiovascular risk factors to right ventricular structure and function as determined by magnetic resonance imaging (results from the multi-ethnic study of atherosclerosis).

Authors:  Harjit Chahal; Craig Johnson; Harikrishna Tandri; Aditya Jain; W Gregory Hundley; R Graham Barr; Steven M Kawut; Joao A C Lima; David A Bluemke
Journal:  Am J Cardiol       Date:  2010-05-13       Impact factor: 2.778

Review 6.  Contemporary narrative review on left atrial strain mechanics in echocardiography: cardiomyopathy, valvular heart disease and beyond.

Authors:  Vardhmaan Jain; Raktim Ghosh; Manasvi Gupta; Yoshihito Saijo; Agam Bansal; Medhat Farwati; Rachel Marcus; Allan Klein; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

7.  Does gender affect the association between right ventricular strain and arterial hypertension?

Authors:  Marijana Tadic; Cesare Cuspidi; Branislava Ivanovic; Biljana Pencic; Guido Grassi; Vera Celic
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-09       Impact factor: 3.738

8.  Effect of systemic hypertension on right ventricular morphology and function: an echocardiographic study.

Authors:  A A Akintunde; P O Akinwusi; O B Familoni; O G Opadijo
Journal:  Cardiovasc J Afr       Date:  2010 Sep-Oct       Impact factor: 1.167

Review 9.  Right heart remodeling induced by arterial hypertension: Could strain assessment be helpful?

Authors:  Marijana Tadic; Cesare Cuspidi; Michele Bombelli; Guido Grassi
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-25       Impact factor: 3.738

Review 10.  Echocardiographic Assessment of the Right Ventricle, from the Conventional Approach to Speckle Tracking and Three-Dimensional Imaging, and Insights into the "Right Way" to Explore the Forgotten Chamber.

Authors:  Antoine Kossaify
Journal:  Clin Med Insights Cardiol       Date:  2015-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.